458 related articles for article (PubMed ID: 29484542)
1. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
3. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
4. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
Krull KR; Cheung YT; Liu W; Fellah S; Reddick WE; Brinkman TM; Kimberg C; Ogg R; Srivastava D; Pui CH; Robison LL; Hudson MM
J Clin Oncol; 2016 Aug; 34(22):2644-53. PubMed ID: 27269941
[TBL] [Abstract][Full Text] [Related]
6. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
Chiou SS; Lin PC; Liao YM; Yang P
Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362
[TBL] [Abstract][Full Text] [Related]
8. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
Cheung YT; Edelmann MN; Mulrooney DA; Green DM; Chemaitilly W; John N; Robison LL; Hudson MM; Krull KR
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1259-67. PubMed ID: 27345588
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
[TBL] [Abstract][Full Text] [Related]
11. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
[TBL] [Abstract][Full Text] [Related]
12. Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy.
Cheung YT; Chemaitilly W; Mulrooney DA; Brinkman TM; Liu W; Banerjee P; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Psychoneuroendocrinology; 2017 Feb; 76():114-118. PubMed ID: 27907849
[TBL] [Abstract][Full Text] [Related]
13. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
Brace KM; Lee WW; Cole PD; Sussman ES
J Clin Exp Neuropsychol; 2019 Oct; 41(8):814-831. PubMed ID: 31156064
[No Abstract] [Full Text] [Related]
14. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
Sabin ND; Cheung YT; Reddick WE; Bhojwani D; Liu W; Glass JO; Brinkman TM; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1919-1925. PubMed ID: 30213807
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
17. Behavioral symptoms and psychiatric disorders in child and adolescent long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Liu W; Cheung YT; Brinkman TM; Banerjee P; Srivastava D; Nolan VG; Zhang H; Gurney JG; Pui CH; Robison LL; Hudson MM; Krull KR
Psychooncology; 2018 Jun; 27(6):1597-1607. PubMed ID: 29521470
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia.
van der Plas E; Spencer Noakes TL; Butcher DT; Weksberg R; Galin-Corini L; Wanstall EA; Te P; Hopf L; Guger S; Hitzler J; Schachar RJ; Ito S; Nieman BJ
Pediatr Res; 2021 Aug; 90(2):419-426. PubMed ID: 33203967
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.
Cheung YT; Krull KR
Neurosci Biobehav Rev; 2015 Jun; 53():108-20. PubMed ID: 25857254
[TBL] [Abstract][Full Text] [Related]
20. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Mennes M; Stiers P; Vandenbussche E; Vercruysse G; Uyttebroeck A; De Meyer G; Van Cool SW
Pediatr Blood Cancer; 2005 May; 44(5):478-86. PubMed ID: 15918215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
